Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder

被引:3
|
作者
Dalbagni, G
Mazumdar, M
Russo, P
Sheinfeld, J
Donat, SM
Bochner, BH
Herr, HW
Sogani, P
Ginty, J
Bajorin, DF
机构
来源
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词
D O I
10.1016/S0022-5347(18)37536-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:72 / 72
页数:1
相关论文
共 50 条
  • [21] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, Guarionex
    Sui, Wilson
    Pak, Jamie
    Abate-Shen, Cory
    Lee, Shing
    Anderson, Christopher
    Holder, Dara
    McKiernan, James
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
  • [22] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Nong Xu
    Xiao Chen Zhang
    Jian Ping Xiong
    Wei Jia Fang
    Lan Fang Yu
    Jiong Qian
    Ling Zhang
    [J]. BMC Cancer, 7
  • [23] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
  • [24] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 409S - 409S
  • [25] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Xu, Nong
    Zhang, Xiao Chen
    Xiong, Jian Ping
    Fang, Wei Jia
    Yu, Lan Fang
    Qian, Jiong
    Zhang, Ling
    [J]. BMC CANCER, 2007, 7 (1)
  • [26] A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Patel, Sunil H.
    Gabrielson, Andrew T.
    Chan, Sin
    Schwartz, Deborah
    Collins, Connie
    Singla, Nirmish
    Trock, Bruce
    Bivalacqua, Trinity J.
    Hahn, Noah
    Kates, Max R.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E245 - E246
  • [27] Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions
    Serretta, V
    Galuffo, A
    Pavone, C
    Allegro, R
    Pavone-Macaluso, M
    [J]. UROLOGY, 2005, 65 (01) : 65 - 69
  • [28] Mycotic aortic aneurysm formation following intravesical BCG treatment for transitional cell carcinoma of the bladder
    Flynn, David
    Ogi, Akihiro
    Subedi, Shradha
    Langton, Jonathan
    Choong, Keat
    O'Donnell, Jill
    [J]. BMJ CASE REPORTS, 2021, 14 (11)
  • [29] DYSTROPHIC BLADDER WALL CALCIFICATIONS FOLLOWING INTRAVESICAL BCG TREATMENT FOR SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF BLADDER
    SPIRNAK, JP
    LUBKE, WL
    THOMPSON, IM
    LOPEZ, M
    [J]. UROLOGY, 1993, 42 (01) : 89 - 92
  • [30] Phase 1 dose-escalation trial of intravesical CG0070 for superficial transitional cell carcinoma (TCC) of the bladder after BCG failure
    Maslyar, Daniel J.
    McKiernan, James
    Nemunaitis, John
    Arseneau, James
    Stephenson, Joe
    Burke, James
    Neal, Kristina
    Aimi, Junko
    Lamm, Don
    [J]. JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 675 - 675